Every intervention Outliyr has scored for inflammation, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for inflammation; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
90 of 129 evaluated interventions score 3.0+ out of 10 for inflammation · 16 comparisons
Molecular Hydrogen earns 8.0/10 for inflammation control because LeBaron 2020 reports 60 participants over 24 weeks; reported improved lipids, glucose, HbA1c, inflammatory markers, and redox markers. Sim 2020 points in the same…
Read the Molecular Hydrogen report →For anti inflammatory, Celebrex (Celecoxib) earns 8.0/10 because the evidence points to a plausible use case without proving a universal response. Farag N et al. 2025 is the best anchor here because…
Read the Celebrex (Celecoxib) report →Inflammation is one of the better Red Light Therapy targets, scoring 7.5/10 because Hamblin 2017 details NF-kB modulation, mitochondrial signaling, and local inflammatory effects. The practical strength is localized inflammation: joints, tendons,…
Read the Red Light Therapy report →For inflammation control, Astaxanthin scores 7.5/10 because Malcangi 2026 reports 15 human RCTs; consistent reductions in several inflammatory and oxidative-stress markers plus increases in antioxidant capacity; better trials still needed. Ma 2022…
Read the Astaxanthin report →For anti-inflammatory, Infrared Sauna lands at 7.5/10 because Oosterveld 2009 supports the strongest part of the claim. The existing rationale points to this narrower claim: Heat exposure can influence inflammatory signaling through…
Read the Infrared Sauna report →Anti-inflammatory scoring sits at 7.5/10 because Semaglutide reduces inflammatory load mainly through weight loss and metabolic repair, with Lincoff 2023 giving hard-outcome relevance in high-risk obesity. This is not a direct anti-inflammatory…
Read the Semaglutide report →Evidence for Taurine in inflammation control lands at 7.0/10 because Ahmadian 2017 reports Heart-failure RCT; 500 mg three times daily for 2 weeks affected atherogenic and inflammatory markers. The score stays conditional…
Read the Taurine report →Glycine anti inflammatory earns 7.0/10 because Kumar 2023 anchors the most relevant signal. Glycine fits anti inflammatory because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the…
Read the Glycine report →BPC-157 anti inflammatory earns 7.0/10 because Vasireddi 2025 anchors the most relevant signal. BPC-157 fits anti inflammatory when the target is tissue repair, vascular recruitment, or inflammation control, but the case still…
Read the BPC-157 report →Anti Inflammatory is a 7.0/10 fit for GHK-Cu, based on the evidence summarized in Pickart L, Margolina 2018. The v0 anti-inflammatory score is retained because copper-tripeptide biology intersects with IL-6, TGF-beta, tissue…
Read the GHK-Cu report →The anti inflammatory use case earns 7.0/10 for Lactoferrin, anchored by Ariff et al. 2025. The anti-inflammatory subrating stays at 7.0 because lactoferrin consistently affects inflammatory signaling, but clinical translation varies. Berthon…
Read the Lactoferrin report →Thymosin Alpha-1 anti inflammatory earns 7.0/10 because Wu 2025 anchors the most relevant signal. Thymosin Alpha-1 fits anti inflammatory when immune modulation is medically relevant and monitored rather than casually guessed. The…
Read the Thymosin Alpha-1 report →Evidence puts Senolytics at 7.0/10 for anti inflammatory, mainly through Farr et al. 2024. SASP suppression is central to the mechanism; Hickson 2019 supports marker movement for D+Q but is preliminary and…
Read the Senolytics report →Ozone Therapy earns 7.0/10 for inflammation control because Sagai 2011 reports Personally verified mechanism review; Nrf2 activation, NF-kB modulation, lipid oxidation products, dose-toxicity tension. The score stays conditional because Ozone Therapy still…
Read the Ozone Therapy report →Vagus Nerve Stimulation reaches 6.8/10 for anti inflammatory when the goal matches the population in Kim et al. 2022. The cholinergic anti-inflammatory pathway has direct human support from implanted VNS work, including…
Read the Vagus Nerve Stimulation report →For readers prioritizing anti inflammatory, PEMF (Pulsed Electromagnetic Field Therapy) scores 6.8/10 today. NF-kB modulation and cytokine shifts provide the anti-inflammatory rationale. Rohde 2015 found lower postoperative interleukin-1beta, pain, inflammation, and narcotic…
Read the PEMF (Pulsed Electromagnetic Field Therapy) report →Rapamycin anti inflammatory earns 6.8/10 because Harrison 2009 anchors the most relevant signal. Rapamycin fits anti inflammatory when mTORC1 modulation, autophagy, immune aging, or senescence biology is the actual target. The score…
Read the Rapamycin report →The anti-inflammatory case for Ca-AKG (Calcium Alpha-Ketoglutarate) is 6.8/10 because Demidenko 2021 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: IL-10 dependence is supported by this…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report →Zone 2 Cardio's 6.5/10 anti-inflammatory score starts with Vabishchevich 2026, then gets narrowed by the evidence gap. The existing rationale points to this narrower claim: Moderate aerobic training lowers chronic inflammatory burden…
Read the Zone 2 Cardio report →Anti-inflammatory effect scores 6.5/10. Laukkanen 2018 found sauna frequency inversely associated with C-reactive protein in 2,084 men, with mean CRP falling from 2.41 at 1 session per week to 1.65 at 4…
Read the Traditional Sauna (Finnish Dry-Heat) report →Anti-inflammatory action scores 6.5/10. Multiple polyphenol classes lower circulating inflammatory markers including CRP in controlled trials, and the mechanism (modulation of NF-kB signaling and oxidative load) is well characterized. The Crowe-White 2022…
Read the Polyphenols (Dietary) report →The strongest anti inflammatory case puts TB-500 (Thymosin Beta-4 Fragment) at 6.5/10. Anti-inflammatory support is stronger than many other secondary claims. Sosne 2007 reviews corneal anti-inflammatory mechanisms, and Wang 2024 shows pro-resolving…
Read the TB-500 (Thymosin Beta-4 Fragment) report →For inflammation control, KPV (Lys-Pro-Val) scores 6.5/10 because Sung 2025 reports cell and 3D skin model study, not a clinical trial. Dalmasso 2008 points in the same direction, but route, dose, baseline…
Read the KPV (Lys-Pro-Val) report →Curcumin lowers C-reactive protein consistently across trials. A 2023 umbrella meta-analysis pooling over 5,800 participants (Naghsh and colleagues) reported a CRP effect size around 0.74, most pronounced under 10 weeks and at…
Read the Curcumin report →The anti-inflammatory potential of Tirzepatide scores 6.2/10, based on data from the obesity RCT showing modest reductions in CRP Jastreboff 2022. Tirzepatide's anti-inflammatory effect appears secondary to weight loss and metabolic improvement…
Read the Tirzepatide report →High-Dose Melatonin has a moderate anti-inflammatory score because sepsis and COVID trials used higher doses and reported clinical or inflammatory improvements. A phase I sepsis dose-escalation study tested 20 to 100 mg…
Read the High-Dose Melatonin report →Anti-inflammatory lands at 6.0/10 because the inflammation evidence is real but smaller than the cardiometabolic case. Shahraki Jazinaki 2025 pooled 7 trials in 283 subjects and found C-reactive protein falling 0.55 mg/L,…
Read the Spirulina report →The anti-inflammatory rating for Earthing is 6.0 /10, based on a modest postoperative study that observed lower inflammatory markers in 84 patients (Sokal 2025). Earthing's anti-inflammatory claim rests on this single trial…
Read the Earthing report →The main limitation behind Omega-3's 6.0/10 anti inflammatory score is that the evidence points to a plausible use case without proving a universal response. Kaviani et al. 2022 is the best anchor…
Read the Omega-3 report →Fucoidan scores 6.0 out of 10 for anti-inflammatory use. In advanced cancer patients, Takahashi 2018 reported significant reductions in IL-1 beta, IL-6, and TNF-alpha within two weeks of fucoidan supplementation, and the…
Read the Fucoidan (Brown Seaweed Polysaccharide) report →The anti-inflammatory rating for Hyperbaric Oxygen Therapy is 5.9/10, reflecting results from a phase II randomised trial of 80 long-COVID patients Kjellberg 2025. Hyperbaric Oxygen Therapy is proposed to modulate inflammation in…
Read the Hyperbaric Oxygen Therapy report →Metformin scores 5.8/10 for the anti-inflammatory use case, based on modest CRP reductions reported in diabetic trials such as the UK Prospective Diabetes Study Group 1998 UK Prospective Diabetes Study Group 1998.…
Read the Metformin report →For anti inflammatory, Time-Restricted Eating earns 5.7/10 because the evidence points to a plausible use case without proving a universal response. World Anti-Doping Agency 2026 is the best anchor here because it…
Read the Time-Restricted Eating report →A cautious anti inflammatory score of 5.5/10 fits HRV Biofeedback, with Vann-Adibe et al. 2025 preventing a stronger claim. Vagal anti-inflammatory pathway; reduced TNF-alpha in one small RCT. Mechanism plausible, direct human…
Read the HRV Biofeedback report →The Norwegian 4x4 protocol scores 5.5/10 for anti-inflammatory potential, with a meta-analysis reporting a modest 10 % reduction in resting C-reactive protein after 12 weeks of similar high-intensity interval training Poon 2024.…
Read the Norwegian 4×4 report →The inflammation control case for Essential Amino Acids is 5.5/10 because Hagiyama 2024 reports 12 RCTs; 622 patients; low-certainty improvement in patient-reported outcomes and very-low-certainty strength signal after lower-limb surgeries. Wittholz 2024…
Read the Essential Amino Acids report →Shilajit anti inflammatory earns 5.5/10 because Pandit 2016 anchors the most relevant signal. Shilajit fits anti inflammatory when purified resin is matched to hormones, sperm parameters, strength fatigue, bone markers, or energy…
Read the Shilajit report →The anti-inflammatory potential of Whole-Body Vibration scores 5.5/10, based on mixed findings in a meta-analysis Wang et al. 2024. Whole-Body Vibration produces an acute inflammatory response that resembles moderate exercise, which may…
Read the Whole-Body Vibration report →The main limitation behind Ashwagandha's 5.5/10 anti inflammatory score is that the evidence points to a plausible use case without proving a universal response. Fatima et al. 2024 is the best anchor…
Read the Ashwagandha report →Anti-inflammatory effects score 5.5/10. Kumar 2023 reported IL-6 down 78 percent and TNF-alpha down 54 percent at 16 weeks, with the anti-inflammatory cytokine IL-10 nearly doubling, a consistent and sizable shift across…
Read the GlyNAC (Glycine + N-Acetylcysteine) report →Anti-inflammatory support scores 5.5/10. The mechanism is sound: ergothioneine dampens reactive oxygen species and has reduced inflammatory markers in cell and animal models, and the cardiovascular protection seen in Smith 2020 is…
Read the Ergothioneine report →Mechanistically, Ketogenic Diet scores 5.5/10 for anti inflammatory because the evidence points to a plausible use case without proving a universal response. McKenzie AL et al. 2024 is the best anchor here…
Read the Ketogenic Diet report →For readers prioritizing anti inflammatory, Urolithin A scores 5.5/10 today. Denk 2025 and the 2024 systematic review support anti-inflammatory and immune-metabolic signals, though disease-level inflammation outcomes are unproven. That makes Urolithin A…
Read the Urolithin A report →A 5.5/10 for anti-inflammatory fits Methylene Blue because Rothenberg 2025 supports direction more than certainty. The existing rationale points to this narrower claim: Anti-inflammatory claims are plausible through nitric-oxide pathway modulation, but…
Read the Methylene Blue report →Vitamin C scores 5.0/10 as an anti-inflammatory. It lowers some oxidative-stress and inflammatory markers in trials, consistent with its reducing-agent chemistry, and the blood pressure and glycemic improvements in Juraschek 2012 and…
Read the Vitamin C (Ascorbic Acid) report →For anti-inflammatory, Spermidine lands at 5.0/10 because Schwarz 2022 supports the strongest part of the claim. The existing rationale points to this narrower claim: this verified source measured biomarkers in older adults,…
Read the Spermidine report →Lion's Mane anti inflammatory earns 5.0/10 because Menon 2025 anchors the most relevant signal. Lion's Mane fits anti inflammatory when the goal is gentle mushroom-based support for cognition, mood, nerve biology, or…
Read the Lion’s Mane report →Anti-inflammatory support sits at 5.0/10. Several trials report modest reductions in inflammatory markers like CRP and IL-6 with CoQ10, consistent with its membrane-antioxidant action, and this plausibly contributes to its cardiovascular effects.…
Read the Coenzyme Q10 (CoQ10 / Ubiquinol) report →Meta-analysis of human trials by Ou 2020 found no overall effect on CRP, IL-6, or TNF-alpha, with subgroup signals only. Disease-specific signals exist, including reductions in oxidative stress and inflammatory markers in…
Read the Quercetin report →Anti-inflammatory effect is biologically real but clinical translation is mixed. Selected cytokine and gastritis marker shifts are documented in small trials, and NRF2 activation suppresses NF-kB signaling preclinically. The negatives are notable:…
Read the Sulforaphane report →Anti-inflammatory effects score 5.0/10 as a reasonable but indirect inference. Glutathione status modulates redox-sensitive inflammatory signaling, and the liposomal pilot reported a 35 percent drop in the oxidative marker 8-isoprostane. But no…
Read the Glutathione (GSH) report →Tesamorelin has a 5.0/10 anti inflammatory case because Fourman et al. 2020 supports a plausible benefit. Stanley 2011 reported inflammatory-marker changes that tracked with visceral-fat reduction, and Fourman 2020 showed downregulation of…
Read the Tesamorelin report →Butyrate's anti-inflammatory action is well grounded in mechanism, since it inhibits HDACs and promotes regulatory T cells in the gut. In the active ulcerative colitis trial (n=36), oral sodium butyrate lowered ESR…
Read the Sodium Butyrate report →Anti-inflammatory effects are plausible as a polyphenol-class pattern, but resveratrol-specific clinical superiority is not established. Tomé-Carneiro 2012 reported favorable inflammatory and fibrinolytic markers in CVD-risk patients, while Akbari 2020 found mixed lipid…
Read the Resveratrol report →The practical anti-inflammatory read on Retatrutide is 5.0/10 because Jastreboff 2023 anchors the strongest signal. The existing rationale points to this narrower claim: Inflammation may improve secondarily through fat loss, liver-fat reduction,…
Read the Retatrutide report →Anti-inflammatory action is well-supported preclinically and biologically, but human direct-inflammation endpoints are thin. Tβ4 dampens NF-κB-driven cytokine output, and its cleavage product Ac-SDKP is independently anti-inflammatory and antifibrotic across heart, kidney, and…
Read the Thymosin Beta-4 (Tβ4) report →Anti-inflammatory effects are mechanistically supported and appear in cardiometabolic and retinal models, but clinical inflammatory endpoints are weaker than mood and sleep outcomes.
Read the Saffron report →Vahedi-Mazdabadi 2023 supports inflammatory-biomarker reductions in randomized trials involving berberine or barberry. Translation to clinical inflammatory disease outcomes remains narrower than the mechanism suggests.
Read the Berberine report →Anti-inflammatory action is the core mechanism, well supported preclinically but thin on direct human inflammation endpoints. Activating the innate repair receptor dampens innate immune-cell activation and reprograms a tissue-damaging environment into a…
Read the ARA-290 (Cibinetide) report →Zhai 2017 showed anti-inflammatory and anti-MRSA effects in mice, including reduced pro-inflammatory cytokine signaling. This supports a preclinical inflammation signal but not a human anti-inflammatory indication.
Read the MOTS-c report →Consistent preclinical anti-inflammatory signal across reishi, cordyceps, and chaga polysaccharides and triterpenes, plus an O. sinensis dialysis meta-analysis showing lower CRP, but human outcome certainty is low.
Read the Adaptogenic Mushrooms (Reishi, Cordyceps, Chaga) report →Anti-inflammatory use lands at 4.5 out of 10. Choi 2007 showed Pinus densiflora pollen extract at 100 to 200 mg/kg inhibited formalin pain and carrageenan edema in mice comparably to indomethacin, and…
Read the Pine Pollen report →TRT may modestly improve inflammatory markers in hypogonadal men with metabolic syndrome, but it is not a primary anti-inflammatory therapy. Lifestyle, adiposity reduction, periodontal care, sleep, and omega-3 status usually matter more.
Read the TRT (Testosterone Replacement Therapy) report →ERR activation modulated inflammatory gene expression in preclinical kidney models. Wang et al. 2023 supports a mouse anti-inflammatory signal, but there is no human CRP, cytokine, symptom, or inflammatory-disease endpoint.
Read the SLU-PP-332 report →Strong preclinical anti-inflammatory mechanism but limited direct human outcome data; rated cautiously below neutral pending controlled human inflammatory-marker trials.
Read the Full-Spectrum Hemp (CBD) report →Some inflammatory-marker shifts appear in exercise studies, but BFR-specific anti-inflammatory evidence is limited and secondary.
Read the Blood-Flow Restriction Training report →Glutathione repletion lowers oxidative and inflammatory load mechanistically, but dedicated anti-inflammatory clinical endpoints are inconsistent across trials.
Read the NAC (N-Acetylcysteine) report →Chronic training lowers systemic inflammation over months, but the all-out efforts of SIT are an acute oxidative and inflammatory stressor; net benefit depends on adequate recovery between sessions.
Read the Sprinting (Sprint Interval Training) report →Lactoferrin, PRPs, and gut-barrier effects support an anti-inflammatory rationale, but human outcomes are indirect. Hajihashemi 2024 describes mixed gastrointestinal disease findings rather than broad anti-inflammatory clinical proof.
Read the Colostrum report →Thymulin suppresses inflammatory signaling across several animal and cell models. It selectively reduced LPS-induced IL-1beta and blocked NF-kappaB nuclear movement in an alveolar model, per Haddad 2009, and it modulated NF-kappaB and…
Read the Thymulin (Zinc-Thymulin) report →Reductions in cardiovascular and liver markers are consistent with lower inflammatory load, but few chlorella trials measure inflammation directly as the primary endpoint, keeping this an inferred rather than demonstrated benefit.
Read the Chlorella report →Reduces mitochondrial ROS-driven inflammatory signaling in the mechanism literature, but human inflammatory biomarker evidence is limited and not a primary clinical endpoint strength.
Read the SS-31 (Elamipretide) report →BHB inhibits the NLRP3 inflammasome in preclinical models, a real and interesting mechanism, but human anti-inflammatory outcome data for exogenous ketones is sparse. Mechanism outpaces clinical proof.
Read the Exogenous Ketones report →Robinson 2024 (Robinson 2024) did not show a reliable full-cohort hs-CRP benefit over 12 weeks. Phang / Chooi TANGO did not establish systemic inflammatory-marker reduction as the main C15-specific outcome. Claims around…
Read the C15 (Pentadecanoic Acid) report →The anti-inflammatory effect is mechanistically well-described, especially for joints, where pentosan lowers inflammatory mediators and helps normalize joint fluid, per Ghosh 1999. That maps onto the clinical improvements seen in the small…
Read the Pentosan Polysulfate (Elmiron) report →Cortisol reduction is adjacent to inflammation control, but no direct CRP, IL-6, or clinical inflammatory-disease RCT supports a higher score.
Read the Tongkat Ali report →Anti-inflammatory activity is VIP's best-characterized and most defensible claim, and it is the use most people are chasing. The cleanest human demonstration is a 4-week open-label inhaled-VIP study in 20 sarcoidosis patients…
Read the VIP (Vasoactive Intestinal Peptide) report →Muscle contraction releases myokines that can support lower inflammatory tone, but WB-EMS trials do not consistently improve inflammatory biomarkers. The score reflects indirect exercise physiology rather than direct anti-inflammatory evidence.
Read the Full-Body EMS report →Indirect. Regular moderate aerobic exercise lowers chronic inflammatory markers, but excessive loaded volume can raise them; the net depends on dose and recovery.
Read the Rucking (Weighted Walking) report →Anti-inflammatory effects rate 3.5/10. Any benefit is indirect via joint and tissue support rather than systemic inflammatory-marker suppression. HA is not a reliable way to move CRP or IL-6, and trials do…
Read the Hyaluronic Acid report →NF-kB suppression and IKK inhibition are well-characterized in cell and rodent inflammation models. Salehi 2019 summarizes broad preclinical anti-inflammatory data. No human RCT has measured inflammatory markers as a primary endpoint for…
Read the Apigenin report →NAD+ biology intersects with inflammatory pathways, but human NMN anti-inflammatory outcomes are not established. Keep this in the indirect-mechanism bucket.
Read the NMN (Nicotinamide Mononucleotide) report →Elhassan 2019, Norheim 2024, and Ahmadi 2025 support inflammatory-marker interest, but clinical outcome translation remains early.
Read the NR (Nicotinamide Riboside) report →Nasal irrigation reduces local inflammatory symptoms, but there is no systemic anti-inflammatory marker trial of the oral product.
Read the Quinton Marine Plasma (Seawater Minerals) report →UC-II has an immune-tolerance mechanism relevant to synovial inflammation, and Lugo 2013 supports joint-function benefit in healthy adults. Systemic inflammation endpoints remain weak.
Read the Collagen Peptides report →TNF-alpha and IL-6 reductions in mouse LPS-depression model (Tallerova 2011) and IL-6, IL-17, IL-4 reductions in C57BL/6 anxious-depression model (Tallerova 2011 EKF). No human inflammation RCT.
Read the Bromantane (Ladasten) report →Post-ischemic immune and inflammatory gene-expression effects appear in Medvedeva et al. 2014, but Semax is not a primary anti-inflammatory intervention for systemic conditions.
Read the Semax report →Inflammation-gene modulation exists in mouse spleen models, including Kolomin 2014, but Selank is not a proven anti-inflammatory therapy.
Read the Selank report →Antioxidant and oxidative-stress findings imply possible downstream anti-inflammatory effects, but direct inflammatory-marker evidence is thin. No verified human Epitalon trial measured CRP, IL-6, TNF-alpha, pain inflammation, or disease-specific inflammatory outcomes.
Read the Epitalon report →hsCRP fell across trials, consistent with weight loss; not an anti-inflammatory drug in its own right.
Read the Orforglipron (Foundayo) report →Nothing matches those filters.
Head-to-head reports and category rankings that name a winner on this use case.
Tirzepatide, at 6.1, then semaglutide at 6.0, then orforglipron at 5.8 if you want the pill. All three are approved, all three have real trial evidence, and all…
Ca-AKG, urolithin A and MOTS-c tie at 6.5, and only the first two are things you can legally buy. SS-31 follows at 6.0. The bottom three score low…
GHK-Cu wins this on evidence. It has human wound and skin data behind it. AHK-Cu has one unreplicated dish study and no human trial at all. Use GHK-Cu…
Neither, if fat loss is the goal. Both score 2.0 on body composition, which is the row a vendor sells them on. AOD-9604 scores 4.6 overall and its…
BPC-157 for structural repair, KPV for inflammation you cannot afford to stimulate. BPC-157 scores gut health 9.0 against KPV's 7.0 and wins nearly every other row, because it…
No. Omega-3 scores 6.8 and C15:0 4.9, and the evidence gap is larger than the score gap. C15:0 has two small human trials. Omega-3 has outcome trials, prescription…
Different jobs, same shelf. Quercetin scores 6.8 and curcumin 6.5, which decides nothing. Curcumin wins joints, inflammatory markers, gut and mood. Quercetin wins allergies, blood pressure, uric acid…
Spermidine scores 7.6 and urolithin A 6.5, and they clean up different messes. Spermidine drives broad autophagy: autophagy 8.0, cardiovascular 7.8, longevity 7.5. Urolithin A drives selective mitophagy…
Sulforaphane scores 6.8 and glutathione 6.2, and both have a delivery problem. Sulforaphane needs active myrosinase or you absorb half as much. Plain oral glutathione barely raises blood…
Thymulin scores 6.6, thymalin 5.9, and they are not interchangeable. Thymulin is a defined zinc-dependent peptide with receptor-level science, stronger inflammation data and a much cheaper course. Thymalin…
HBOT scores 6.2 and ozone 5.1, but ozone wins several use cases outright. Pick HBOT for wounds, cognition and neuro recovery, at $3,000 to $6,000 a month. Pick…
Lactoferrin scores 7.3 against colostrum's 6.8, and lactoferrin is one protein inside colostrum. Buy lactoferrin when iron handling, acne or H. pylori is the target, at $25 to…
Molecular Hydrogen, at 8.0 out of 10 for inflammation. Molecular Hydrogen earns 8.0/10 for inflammation control because LeBaron 2020 reports 60 participants over 24 weeks; reported improved lipids, glucose, HbA1c, inflammatory markers, and redox markers.
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 7.0 out of 10 for inflammation.
90 of the 129 interventions evaluated for inflammation score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
